NATCOPHARM.NS

Natco Pharma Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$112.97B

PE Ratio

25.11691207403599

EV to Ebitda

—

Earnings Yield

329596196.57%

Revenue (TTM)

$291.0M

Net Income (TTM)

$47.0M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

-12.10%

Profit Margin

16.16%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$112.97B

Revenue TTM$291.0M

Shares Outstanding182.6M

Float89518819

Insider Ownership51.25%

Institutional Ownership19.18%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)-12.10%

Rev Growth Est 1Y Forward0.0650

EPS Growth (Quarterly YoY)-22.50%

EPS Growth Est Quarterly0

LT EPS Growth Estimates-5.10%

Operations14 fields›

Revenue TTM$291.0M

Gross Margin TTM56.56%

Gross Margin (Quarterly)76.57%

Operating Margin TTM18.66%

Operating Margin (Quarterly)13.08%

Profit Margin TTM16.16%

Profit Margin (Quarterly)12.65%

Net Income TTM$47.0M

EPS TTM21.31

EBIT Margin TTM25.06%

EBITDA TTM$72.9M

Capex % of Revenue TTM13.64%

Capital Expenditures$39.7M

FCF % of Revenue (Quarterly)-8.15%

Efficiency1 fields›

ROA5.56%

Valuation7 fields›

P/E (TTM)25.11691207403599

P/E Forward0

EV/Revenues (TTM)3.8896

Price To Book2.1373523498348392

Earnings Yield329596196.57%

Dividend Yield0.00%

Payout Ratio34.92%

Liquidity6 fields›

Cash Per Share43.83136210289363

Current Ratio3.5152027027027026

Goodwill & Intangibles$1911.00T

Total Assets$50779.00T

Shareholders Equity$45713.00T

Interest Expense$185.0M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio34.92%

Earnings Yield329596196.57%